The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer
Open accessAbstract
Purpose: To evaluate neoadjuvant capecitabine/oxaliplatin before chemoradiotherapy (CRT) and total mesorectal excision (TME) in newly diagnosed patients with magnetic resonance imaging (MRI) –defined poor-risk rectal cancer. Patients and Methods: MRI criteria for poor-risk rectal cancer were tumors within 1 mm of mesorectal fascia (ie, circumferential resection margin threatened), T3 tumors at or below levators, tumors extending ≥ 5 mm into perirectal fat, T4 tumors, and T1-4N2 tumors. Patients received 12 weeks of neoadjuvant capecitabine/oxaliplatin followed by concomitant capecitabine and radiotherapy. TME was planned 6 weeks after CRT. Postoperatively, patients received another 12 weeks of capecitabine. Results: Between November 2001 and August 2004, 77 eligible patients were recruited. After neoadjuvant capecitabine/oxaliplatin, the radiologic response rate was 88%. In addition, 86% of patients had symptomatic responses in a median of 32 days (ie, just over one cycle of capecitabine/oxaliplatin). After CRT, the tumor response rate was increased to 97%. Three patients remained inoperable. Sixty-seven patients proceeded to TME, and all but one patient had R0 resection. Pathologic complete response was observed in 16 patients (24%; 95% CI, 14% to 36%), and in an additional 32 patients (48%), only microscopic tumor foci were found on surgical specimens. Four deaths occurred during neoadjuvant capecitabine/oxaliplatin therapy as a result of pulmonary embolism, ischemic heart disease, sudden death with history of chest pain, and neutropenic colitis. Conclusion: Capecitabine/oxaliplatin before synchronous CRT and TME results in substantial tumor regression, rapid symptomatic response, and achievement of R0 resection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010580 · Cited by 4,205
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.113 · Cited by 2,915
Goldberg, R. M., Sargent, D. J., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Pitot, H. C., & Alberts, S. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.046 · Cited by 2,249
LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION
Quirke, P., Dixon, M. F., Durdey, P., & Williams, N. S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92612-7 · Cited by 1,973
Rectal Cancer: The Basingstoke Experience of Total Mesorectal Excision, 1978-1997
Heald, R. J., Moran, B. J., Ryall, R. D. H., Sexton, R., & MacFarlane, J. K. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.8.894 · Cited by 1,399
Capecitabine as Adjuvant Treatment for Stage III Colon Cancer
Twelves, C., Wong, A., Nowacki, M. P., Abt, M., Burris, H., Carrato, A., Cassidy, J., Cervantes, A., Fagerberg, J., Georgoulias, V., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043116 · Cited by 1,248
Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer
Rödel, C., Martus, P., Papadoupolos, T., Füzesi, L., Klimpfinger, M., Fietkau, R., Liersch, T., Hohenberger, W., Raab, R., Sauer, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.1329 · Cited by 1,215
Role of circumferential margin involvement in the local recurrence of rectal cancer
Adam, I. J., Martin, I. G., Finan, P., Johnston, D., Mohamdee, M. O., Scott, N., Dixon, M. F., & Quirke, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92206-3 · Cited by 1,036
Nagtegaal, I. D., Marijnen, C. A. M., Kranenbarg, E. K., van de Velde, C. J. H., & van Krieken, J. H. J. M. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200203000-00009 · Cited by 746
Brown, G., Radcliffe, A. G., Newcombe, R. G., Dallimore, N. S., Bourne, M. W., & Williams, G. T. (2003) · British Journal of Surgery · doi:10.1002/bjs.4034 · Cited by 734
Self-citationBirbeck, K. F., Macklin, C. P., Tiffin, N. J., Parsons, W., Dixon, M. F., Mapstone, N. P., Abbott, C. R., Scott, N., Finan, P. J., Johnston, D., et al. (2002) · Annals of Surgery · doi:10.1097/00000658-200204000-00001 · Cited by 691
Wibe, A., Rendedal, P. R., Svensson, E., Norstein, J., Eide, T. J., Myrvold, H. E., & Søreide, O. (2002) · British Journal of Surgery · doi:10.1046/j.0007-1323.2001.02024.x · Cited by 672
Cassidy, J., Tabernero, J., Twelves, C., Brunet, R., Butts, C., Conroy, T., Debraud, F., Figer, A., Grossmann, J., Sawada, N., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.069 · Cited by 525
Kapiteijn, E., Putter, H., & van de Velde, C. J. H. (2002) · British Journal of Surgery · doi:10.1046/j.1365-2168.2002.02196.x · Cited by 481
Rectal Carcinoma: Thin-Section MR Imaging for Staging in 28 Patients
Brown, G., Richards, C. J., Newcombe, R. G., Dallimore, N. S., Radcliffe, A. G., Carey, D. P., Bourne, M. W., & Williams, G. T. (1999) · Radiology · doi:10.1148/radiology.211.1.r99ap35215 · Cited by 451
Self-citationThe Modern Abdominoperineal Excision: The Next Challenge After Total Mesorectal Excision
Marr, R., Birbeck, K., Garvican, J., Macklin, C. P., Tiffin, N. J., Parsons, W. J., Dixon, M. F., Mapstone, N. P., Sebag-Montefiore, D., Scott, N., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000167926.60908.15 · Cited by 436
Gunderson, L. L., Sargent, D. J., Tepper, J. E., Wolmark, N., O'Connell, M. J., Begovic, M., Allmer, C., Colangelo, L., Smalley, S. R., Haller, D. G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.173 · Cited by 436
Sample size tables for exact single‐stage phase II designs
A'Hern, R. P. (2001) · Statistics in Medicine · doi:10.1002/sim.721 · Cited by 399
Havenga, K., Enker, W. E., Norstein, J., Moriya, Y., Heald, R. J., van Houwelingen, H. C., & van de Velde, C. J. H. (1999) · European Journal of Surgical Oncology (EJSO) · doi:10.1053/ejso.1999.0659 · Cited by 300
Phase I/II Trial of Capecitabine, Oxaliplatin, and Radiation for Rectal Cancer
Rödel, C., Grabenbauer, G. G., Papadopoulos, T., Hohenberger, W., Schmoll, H.-J., & Sauer, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.505 · Cited by 275
Marijnen, C. A. M., Nagtegaal, I. D., Kapiteijn, E., Kranenbarg, E. K., Noordijk, E. M., van Krieken, J. H. J. M., van de Velde, C. J. H., & Leer, J. W. H. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04291-8 · Cited by 261
Stocchi, L., Nelson, H., Sargent, D. J., O’Connell, M. J., Tepper, J. E., Krook, J. E., Beart, R., & the North Central Cancer Treatment Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3895 · Cited by 212
Gérard, J.-P., Chapet, O., Nemoz, C., Romestaing, P., Mornex, F., Coquard, R., Barbet, N., Atlan, D., Adeleine, P., & Freyer, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.045 · Cited by 206
Brown, G., Davies, S., Williams, G. T., Bourne, M. W., Newcombe, R. G., Radcliffe, A. G., Blethyn, J., Dallimore, N. S., Rees, B. I., Phillips, C. J., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601871 · Cited by 204
Self-citationPreoperative chemoradiation using oral capecitabine in locally advanced rectal cancer
Kim, J.-S., Js, K., Cho, M.-J., Song, K., & Yoon, W. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02856-0 · Cited by 195
Wolmark, N., Wieand, S., Kuebler, J. P., Colangelo, L., & Smith, R. E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.lba3500 · Cited by 176
Aschele, C., Friso, M. L., Pucciarelli, S., Lonardi, S., Sartor, L., Fabris, G., Urso, E. D. L., Bianco, P. D., Sotti, G., Lise, M., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi212 · Cited by 148
Kim, J. C., Kim, T. W., Kim, J. H., Yu, C. S., Kim, H. C., Chang, H. M., Ryu, M. H., Park, J., Ahn, S. D., Lee, S.-W., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.02.046 · Cited by 118
Freyer, G., Bossard, N., Romestaing, P., Mornex, F., Chapet, O., Trillet-Lenoir, V. N., & Gérard, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2433 · Cited by 102
Chau, I., Allen, M. J., Cunningham, D., Tait, D., Brown, G. M., Hill, M. E., Sumpter, K., Rhodes, A., Wotherspoon, A. C., Norman, A. R., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600822 · Cited by 78
Self-citationCarraro, S., Roca, E. L., Cartelli, C., Rafailovici, L., Odena, S. C., Wasserman, E., Gualdrini, U. A., Huertas, E., Barugel, M. E., Ballarino, G., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02933-4 · Cited by 71
Ngan, S. Y., Michael, M., Mackay, J., McKendrick, J., Leong, T., Joon, D. L., & Zalcberg, J. R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602106 · Cited by 70
Bosset, J.-F., Calais, G., Mineur, L., Maingon, P., Radošević-Jelić, L., Daban, A., Bardet, É., Beny, A., Ollier, J., & Collette, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3505 · Cited by 70
Persistent Panhypogammaglobulinemia After CHOP-Rituximab for HIV-Related Lymphoma
Miles, S. A., & Mcgratten, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.282 · Cited by 55
Loi, S., Ngan, S. Y., Hicks, R. J., Mukesh, B. N., Mitchell, P. L. R., Michael, M., Zalcberg, J. R., Leong, T., Joon, D. L., Mackay, J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602413 · Cited by 35
Roberts, T. G., Goulart, B. H. L., Stallings, S., Squitieri, L. S., Chabner, B. A., Finkelstein, S. N., & Clark, J. W. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.2084 · Cited by 12
Cited by
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
Bosset, J.-F., Collette, L., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., & Ollier, J.-C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060829 · Cited by 2,688
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds236 · Cited by 1,510
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0061 · Cited by 944
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Azad, N., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Garrido-Laguna, I., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0051 · Cited by 827
Metadata
- Authors
- Chau, I., Brown, G., Cunningham, D., Tait, D., Wotherspoon, A., Norman, A. R., Tebbutt, N., Hill, M., Ross, P. J., Massey, A., & Oates, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-02-01
- Volume
- 24
- Issue
- 4
- Pages
- 668-674
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2129408765
- Cited by
- 474
- References
- 41
- FWCI
- 17.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.